2024 年至 2032 年血小板市場機會、成長動力、產業趨勢分析與預測

Blood Platelets Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年09月10日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球血小板市場價值為 56 億美元，預計 2024 年至 2032 年複合年成長率為 4.2%。輸血。慢性疾病和血液相關疾病是市場擴張的關鍵驅動力。影響因素包括人口老化、生活方式相關的健康挑戰以及癌症發生率激增。例如，世界衛生組織報告稱，心血管疾病每年導致 1,790 萬人死亡，其中許多與血小板療法有關。

人們對捐血和血小板輸注的認知不斷增強，正成為市場的一個突出趨勢。世界捐血者日等措施有效地強調了血液和血小板捐贈的重要性。此類活動正在推動自願捐贈，從而增加用於基本醫療治療（包括手術和創傷護理）的血小板供應。整個產業分為血小板類型、應用、最終用途和地區。

市面上將血小板類型分為單採血小板和全血血小板。 2023 年，單採血小板領域的收入達到 30 億美元。這種能力對於滿足緊急醫療場景（例如手術和癌症治療）對血小板的高需求至關重要。血小板的應用包括血小板減少症、血液腫瘤學、圍手術期適應症、血友病、血小板功能障礙等。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	56 億美元
預測值	83億美元
複合年成長率	4.2%

2023年，血小板減少症細分市場以44.3%的佔有率引領市場。血小板減少症以血小板數量減少為標誌，通常與自體免疫疾病、感染和某些癌症等疾病有關。這種廣泛發生推動了血小板輸注在其管理和治療中的強勁需求。 2023 年，北美血小板市場規模達15 億美元，預計2024 年至2032 年複合年成長率為2.8%。患者數量的增加，疾病的增加，用於治療和研究的血小板需求也在增加。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性疾病和血液相關疾病的盛行率不斷增加
  - 輸血需求不斷成長
  - 對捐血和血小板輸注的認知提高
  - 外科手術數量不斷增加
- 產業陷阱與挑戰
  - 感染傳播的高風險
  - 治療費用高
成長潛力分析
監管環境
技術景觀
報銷場景
2021-2032 年按地區定價分析
- 北美洲
  - 美國
  - 加拿大
- 歐洲
  - 德國
  - 英國
  - 法國
  - 西班牙
  - 義大利
- 亞太地區
  - 中國
  - 日本
  - 印度
  - 澳洲
  - 韓國
- 拉丁美洲
  - 巴西
  - 墨西哥
  - 阿根廷
- MEA
  - 南非
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
波特的分析
PESTEL分析
未來市場趨勢
差距分析

第 4 章：競爭格局

介紹
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按血小板類型，2021 - 2032

主要趨勢
單採血小板
全血血小板

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
血小板減少症
血液腫瘤學
圍手術期指徵
血友病
血小板功能障礙
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
門診手術中心
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

American Association of Blood Banks (AABB)
American National Red Cross
America's Blood Centers
Blood Centers of America
Brazilian Red Cross
Canada Blood Services
French Red Cross
German Red Cross
Indian Red Cross Society
Italian Red Cross
Japanese Red Cross Society
OneBlood
Red Cross Society of China
South African Red Cross
Spanish Red Cross
The European Blood Alliance (EBA)

簡介目錄

Product Code: 2849

The Global Blood Platelets Market was valued at USD 5.6 billion in 2023 and is projected to grow at a CAGR of 4.2% from 2024 to 2032. This growth is primarily fueled by the rising prevalence of chronic and blood-related disorders, alongside an increasing demand for blood transfusions. Chronic and blood-related disorders are key drivers of market expansion. Contributing factors include an aging population, lifestyle-related health challenges, and a surge in cancer rates. For example, the World Health Organization reports that cardiovascular diseases account for 17.9 million deaths annually, many of which involve platelet therapies.

Growing awareness about blood donations and platelet transfusions is becoming a prominent trend in the market. Initiatives like World Blood Donor Day have effectively underscored the importance of blood and platelet donations. Such campaigns are boosting voluntary donations, thereby increasing the platelet supply for essential medical treatments, including surgeries and trauma care. The overall industry is segmented into platelet type, application, end-use, and region.

The market categorizes platelet types into apheresis-derived platelets and whole-blood-derived platelets. The apheresis-derived platelets segment led with a revenue of USD 3 billion in 2023. Apheresis technology enables the collection of a greater number of platelets from a single donor than traditional whole-blood donations. This capability is vital for addressing the high demand for platelets in urgent medical scenarios, such as surgeries and cancer treatments. Applications of blood platelets include thrombocytopenia, hemato-oncology, perioperative indications, hemophilia, platelet function disorders, and others.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$5.6 Billion
Forecast Value	$8.3 Billion
CAGR	4.2%

In 2023, the thrombocytopenia segment led the market with a 44.3% share. Thrombocytopenia, marked by a reduced platelet count, is commonly linked to disorders like autoimmune diseases, infections, and certain cancers. This widespread occurrence drives a robust demand for platelet transfusions in its management and treatment. North America blood platelets market accounted for USD 1.5 billion in 2023, with projections of a 2.8% CAGR from 2024 to 2032. The region sees a notable incidence of blood disorders, including leukemia and lymphoma.As the number of cancer patients and individuals with blood disorders rises, so does the demand for blood platelets for both treatments and research.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic and blood-related disorders
  - 3.2.1.2 Growing demand for blood transfusions
  - 3.2.1.3 Rise in awareness regarding blood donations and platelets transfusions
  - 3.2.1.4 Rising number of surgical procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High risk of transmissions of infections
  - 3.2.2.2 High cost of the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Pricing analysis, by region, 2021-2032
- 3.7.1 North America
  - 3.7.1.1 U.S.
  - 3.7.1.2 Canada
- 3.7.2 Europe
  - 3.7.2.1 Germany
  - 3.7.2.2 UK
  - 3.7.2.3 France
  - 3.7.2.4 Spain
  - 3.7.2.5 Italy
- 3.7.3 Asia Pacific
  - 3.7.3.1 China
  - 3.7.3.2 Japan
  - 3.7.3.3 India
  - 3.7.3.4 Australia
  - 3.7.3.5 South Korea
- 3.7.4 Latin America
  - 3.7.4.1 Brazil
  - 3.7.4.2 Mexico
  - 3.7.4.3 Argentina
- 3.7.5 MEA
  - 3.7.5.1 South Africa
  - 3.7.5.2 Saudi Arabia
  - 3.7.5.3 UAE
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends
3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Competitive positioning matrix
4.3 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Platelet type, 2021 - 2032 ($ Mn & Units)

5.1 Key trends
5.2 Apheresis derived platelets
5.3 Whole blood derived platelet

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Thrombocytopenia
6.3 Hemato-oncology
6.4 Perioperative indications
6.5 Hemophilia
6.6 Platelet function disorders
6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa